A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial
The Gene Therapy Dream Interrupted: UniQure Investors Face an Unsettling Inquiry
A Sudden Chill for Intellia: FDA Hits Pause on Groundbreaking Gene Therapy Trial